← Back
$XENE All transactions

Xenon Pharmaceuticals Inc.

▼ SELL 10b5-1 Plan

$ Value

$4K

Shares

97

Price

$45

Filed

Dec 3

Insider

Name

MORTIMER IAN

Title

PRESIDENT & CEO

CIK

0001619961

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

31,205

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

Filing Info

Accession No.

0001193125-25-307211

Form Type

4

Issuer CIK

0001582313

MORTIMER IAN's History

Date Ticker Type Value
2026-01-09 XENE A $0
2026-01-09 XENE A $0
2026-01-02 XENE M $300K
2026-01-02 XENE $1.7M
2026-01-02 XENE $93K
2026-01-02 XENE M $0
2025-12-08 XENE $402K
2025-12-08 XENE $93K
2025-12-05 XENE $647K
2025-11-28 XENE $4K

Other Insiders at XENE (90d)

No other insider activity at this issuer in the last 90 days.